STAT3 and cancer: Moreover, the existence of a subpopulation of cells in tumors called cancer stem cells (CSCs) or tumor initiating cells (TICs), responsible for drug resistance, tumor metastasis, and relapse, is also reported to correlate with increasing levels of STAT3 activation [9].